Technical Analyst and Senior Research Software Engineer positions

Imperial College London is recruiting the following positions: Technical analyst (VIMC science & policy team) The post-holder will work in a team alongside three researchers, collaborating closely on the analysis of vaccine impact estimates generated across the consortium and responsive work on key policy questions. Closing date: 6 September Senior... [Read More]

Eight new modelling groups join VIMC

We are delighted to welcome eight new core-funded groups to the Vaccine Impact Modelling Consortium. These groups include modellers from Australia, Benin, Brazil, Kenya, Nigeria, Switzerland, Tunisia, and the UK. As shown below, we are joined by six new groups with disease-specific models of vaccine impact for COVID-19, hepatitis B... [Read More]

New researcher positions at Imperial College London - closing date 15 February 2023

Imperial College London is seeking two Research Associates/Assistants to join the Vaccine Impact Modelling Consortium (VIMC)’s new research programme on the impact of climate change on vaccine-preventable diseases. Both are full-time, three-year posts. Research Assistant/Associate (Climate change impact on infectious diseases) Research Assistant/Associate in Malaria Modelling and Epidemiology The closing... [Read More]

Request for Proposals (RfP) for Modelling Groups

Download our Guide for Applicants here. Download our FAQ here. The Consortium has opened a new Request for Proposals (RfP), as it seeks to recruit the following: groups with disease-specific models of vaccine impact for: malaria COVID-19 meningitis A / multivalent meningococcal conjugate vaccine (MMCV) hepatitis B other cross-cutting groups... [Read More]

VIMC 2.0 Grant Announcement

The Vaccine Impact Modelling Consortium is delighted to have secured renewed funding of £12.8 million (USD $15.4 million) for the next five years, for a new phase of the project. Funding comes from the Bill & Melinda Gates Foundation; Gavi, the Vaccine Alliance; and the Wellcome Trust. This new phase... [Read More]